[1] HERMAN P, COSTA M L, MACHADO M A, et al.Management of hepatic hemangiomas: a 14-year experience[J].J Gastrointest Surg, 2005, 9(6):853-859.
[2] GIULIANTE F, ARDITO F, VELLONE M, et al.Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients[J].Am J Surg, 2011, 201(6):741-748.
[3] KLEINMAN M E, GREIVES M R, CHURGIN S S, et al.Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma[J].Arterioscler Thromb Vasc Biol, 2007, 27(12):2664-2670.
[4] STORCH C, HOEGER P.Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action[J].Br J Dermatol, 2010, 163(2):269-274.
[5] PRZEWRATIL P, SITKIEWICZ A, WYKA K, et al.Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations——preliminary report[J].Pediatr Dermatol, 2009, 26(4):399-404.
[6] 程桂丹, 陆枫林.肝癌中基质金属蛋白酶及其抑制因子的研究进展[J].东南大学学报:医学版, 2010, 29(2):215-220.
[7] MAHAJAN D, MILLER C, HIROSE K, et al.Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab[J].J Hepatol, 2008, 49(5):867-870.
[8] ZHANG W J, YE L Y, WU L Q, et al.Morphologic, phenotypic and functional characteristics of endothelial cells derived from human hepatic cavernous hemangioma[J].J Vasc Res, 2006, 43(6):522-532.
[9] ITINTEANG T, BRASCH H D, TAN S T, et al.Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution[J].J Plast Reconstr Aesthet Surg, 2011, 64(6):759-765.
[10] BREM H, GRESSER I, GROSFELD J, et al.The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis[J].J Pediatr Surg, 1993, 28(10):1253-1257.
[11] LI A, DUBEY S, VARNEY M L, et al.IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis[J].J Immunol, 2003, 170(6):3369-3376.
[12] CAVALLO-MEDVED D, RUDY D, BLUM G, et al.Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation[J].Exp Cell Res, 2009, 315(7):1234-1246.
[13] NEWBY A C.Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates[J].Cardiovasc Res, 2006, 69(3):614-624.
[14] HUANG P H, CHEN Y H, WANG C H, et al.Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells[J].Arterioscler Thromb Vasc Biol, 2009, 29(8):1179-1184. |